Semaglutide linked to significantly lower psychiatric risks in large Sweden and Australia studies
Two recent registry analyses from Sweden and Australia — together following nearly 100,000 adults, including more than 20,000 people who…
Povetacicept in IgA Nephropathy: What the RAINIER Phase 3 Safety Update and FDA Priority Review Actually Mean
Povetacicept’s latest RAINIER Phase 3 update matters for one specific reason: it improves confidence on short-term safety and regulatory momentum,…